Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases
Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases
摘要
关键词
adenosine triphosphatase/C/EBP homologous protein/central retinal artery occlusion/endoplasmic reticulum stress/neuroprotective therapy/retinal ganglion cellKey words
adenosine triphosphatase/C/EBP homologous protein/central retinal artery occlusion/endoplasmic reticulum stress/neuroprotective therapy/retinal ganglion cell引用本文复制引用
Masayuki Hata,Hanako Ohashi Ikeda..Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases[J].中国神经再生研究（英文版）,2017,12(8):1252-1255,4.基金项目
This research was supported in part by research grants from the Astellas Foundation for Research on Metabolic Disorders,the Japan Foundation for Applied Enzymology, the Uehara Memorial Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, YOKOYAMA Foundation for Clinical Pharmacology (YRY1308), Japan Intractable Diseases Research Foundation, Japan Research Foundation for Clinical Pharmacology, ONO Medical Research Foundation, Takeda Science Foundation, Japan National Society for the Pre-vention of Blindness, a Grant-in-Aid for Young Scientists (24791850, to IHO （YRY1308）
15K20255, to HM), the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to IHO), and the Ministry of Health, Labour and Welfare of Japan (to IHO). （to IHO）
